Vienna, Austria

ESTRO 2025

Local time in host city

Programme

9 Sessions
Saturday
May 03
08:00 - 08:55
Strauss 3
Peter Niehoff, Germany
A panel discussion with five experts will explore the future of brachytherapy, based on survey results from participants of the GEC-ESTRO workshop. Panelists include experienced brachytherapists, representatives from ESTRO, young ESTRO members, and a patient advocate. They will discuss key findings from the survey, addressing challenges, innovations, and strategies for advancing brachytherapy. Topics include technological developments, education for future specialists, patient perspectives, and improving accessibility. This discussion aims to bridge clinical practice with emerging trends, fostering collaboration among professionals and patients. By integrating diverse viewpoints and data-driven insights, the panel seeks to define a sustainable and progressive path for brachytherapy.
Panel Discussion
Brachytherapy
Gynecology and Urology
Saturday
May 03
09:00 - 10:00
Stolz 2
Cem Onal, Turkey;
Charlien Berghen, Belgium
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Urology
Saturday
May 03
14:15 - 14:40
Plenary Hall
Award Lecture
Interdisciplinary
Dosimetry & QA / SBRT / Urology
Saturday
May 03
14:40 - 15:05
Plenary Hall
Award Lecture
Interdisciplinary
Dosimetry & QA / SBRT / Urology
Saturday
May 03
15:15 - 16:30
Strauss 3
Ewa Burchardt, Poland;
Luca Tagliaferri, Italy
In this symposium, the latest advancements in Interventional Radio-Immunotherapy will be discussed, emphasizing the synergy between radiotherapy and immunotherapy to improve cancer treatment outcomes, with a special focus on brachytherapy (Interventional radiotherapy). The lectures will cover radiobiological aspects, including the effects of different radiation types and dose rates, and address challenges in dose distribution. Additionally, the symposium will focus on specific tumors such as gynecological, head, neck, skin, and urological cancers. Ongoing clinical trials and future directions will be explored, with an emphasis on personalized approaches based on tumor immune profiling to optimize treatment efficacy.
Symposium
Brachytherapy
Head & Neck / Gynaecology / Skin / Urology
Saturday
May 03
15:15 - 16:15
Stolz 2
Filippo Alongi, Italy;
Jennifer Le Guevelou, France
Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will be recorded and made available via the online platfrom and mobile app.
Poster Discussions
Clinical
Urology
Sunday
May 04
08:00 - 08:40
Strauss 3
Christian Kirisits, Austria
Brachytherapy is a promising treatment option allowing organ preservation for penile carcinoma treatments. This teaching session will give an overview starting with anatomy, pathology and the different treatment options. The entire brachytherapy treatment will be presented in detail including the current state of the art in literature, patient selection criteria and the details on the procedure from implant to treatment planning. Outcome data, experience from a leading center and potential future directions will conclude this session.
Teaching Lecture
Brachytherapy
Urology
Sunday
May 04
08:45 - 10:00
Strauss 3
Marcin Miszczyk, Poland;
Vratislav Strnad, Germany
The optimal indication and implementation of brachytherapy as a boost after external radiotherapy for locally advanced prostate cancer is often a subject of controversy. The aim of the symposium is to present and discuss the current issues about the indication of brachytherapy as a boost from different perspectives - from the point of view of medical physics, radiation biology and radiation oncologists, in particular the current quality of evidence of brachytherapy as a boost with regard to efficacy and side effects. In addition, the current evidence for patient selection and the possible use of artificial intelligence in prostate brachytherapy will be presented.
Symposium
Brachytherapy
Urology
+(event:"a7b130b7-ab19-ef11-9f89-000d3ab97e6f")